4.1 Review

Biologics for the Treatments of Allergic Conditions Severe Asthma

Journal

IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA
Volume 40, Issue 4, Pages 549-564

Publisher

W B SAUNDERS CO-ELSEVIER INC
DOI: 10.1016/j.iac.2020.07.003

Keywords

Severe asthma; Anti IL-33; Benralizumab; Dupilumab; Mepolizumab; Omalizumab; Reslizumab; Tezepelumab

Funding

  1. CRUI2020

Ask authors/readers for more resources

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.1
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available